
Imagine a tiny injection, tucked away in a discreet pen — something you use only when you want to. That’s Vyleesi. Officially, Vyleesi (generic name bremelanotide) is the first and only as‑needed treatment approved by the U.S. Food and Drug Administration (FDA) for certain women with “low libido.”
Vyleesi is for premenopausal women who once had a healthy sexual desire but now — for no clear physical or relationship reason — find that desire slipping. It’s meant for “generalized, acquired” low libido (meaning: low sexual desire across different situations/partners, and not due to illness or medication).
Here’s how the “magic potion” version of Vyleesi goes in marketing:
In a world where libido — for women especially — has often been brushed under the carpet or treated as “just in your head,” Vyleesi comes across like a bold new invitation: control your desire on your own terms.
We don’t have a love‑potion or a guaranteed “turn me on” ray — but researchers believe Vyleesi works on a chemical level in the brain. Bremelanotide is a melanocortin receptor agonist. That means it binds to certain receptors (melanocortin receptors) in the brain — receptors that are part of the neurological signaling pathways involved in sexual desire.
In some women with low libido (for no other diagnosable reason), the balance of neurotransmitters — the brain’s chemical messengers — may be off. Vyleesi aims to rebalance or compensate, essentially giving those signals a “boost.”
The idea is not to “force passion,” but to restore desire to a level where sexual interest feels natural again. For some women in clinical studies, this translated into modest but meaningful improvements — a real change in how they felt about intimacy, their self‑esteem, and their relationship.
But it’s important to be realistic: it is not a guarantee. The effects vary. As one expert quoted when Vyleesi launched said, there’s no magic wand — but for some women with medically diagnosable low libido, the injection can represent a real chance.
Here’s where things get … complicated (and somewhat sobering).
Despite the buzz around “female Viagra” or libido‑boosting drugs, as of 2025 Vyleesi is not registered for women in Singapore — according to sources that track sexual‑health medication availability.
In other words: you cannot legally get a prescription for Vyleesi in a Singapore clinic or pharmacy.
That means any claim of having “Vyleesi for women” in Singapore should be met with skepticism — because buying or importing unregistered prescription medications can pose legal risks and safety hazards.
As with many “female sexual‑health innovations,” there’s interest; but regulation and cultural norms (plus legitimate safety/efficacy scrutiny) are slowing things down.
Because Vyleesi works on the brain and the cardiovascular system — and because it’s a real medicine — there are real potential side effects. Some are mild; some are serious.
Common / mild-ish effects:
More serious / caution‑required effects:
Additionally, some clinicians caution that while Vyleesi can help “reset desire,” desire itself is complex. It often involves relationship dynamics, stress, hormones, emotions — and not always something a drug can “fix.”
In fact, several experts say medication should not be the first line of treatment. Lifestyle, therapy or counseling, hormone evaluation — these often deserve attention first.
What Vyleesi represents:
Why it still isn’t simple:
Since Vyleesi isn’t legally available in Singapore, and because any importation or “underground” sourcing can be risky, here are some safer and more realistic approaches:
Vyleesi is a bold, attention‑grabbing concept — a “desire shot” rather than a daily pill, marketed as a way to reclaim sexual interest on your terms. But it’s not a magic bullet. For some women, it may help; for others, it may disappoint; and for many, it may never even be an option — especially in places like Singapore where it’s not registered.
If you — or someone you know — is struggling with low libido, the most powerful first step is a conversation with a caring, informed healthcare provider. Because sometimes the answer isn’t in a syringe — it’s in understanding, support, and care.
Parnrawee Wadbua